No abstract available.
Porphyromonas gingivalis* ; Porphyromonas* ; Virulence*

No abstract available.
Porphyromonas gingivalis* ; Porphyromonas* ; Virulence*

There are so many considerations for successful restorative dentistry and the periodontal consideration is one of the most important facors to consider. In modern dentistry intracrevicular margin is popular due to esthetic reason. But the marginal tissue recession after intracrevicular restoration is one of the most troublesome phenomena. The marginal tissue recession may be controlled with understanding the mechamsms. In conclusion (1) the inflammation of periodontium must be controlled before intracrevicular restorative percedure (2) the width and thicknes of keratinized gingiva must be evaluated before intracrevicular restorative procedure (3) tooth preparation must follow the natural scallop of CEJ.
Dentistry ; Esthetics ; Gingiva ; Inflammation ; Pectinidae ; Periodontium ; Tooth Cervix ; Tooth Preparation

All contours of the restoration not directly related to occlusion are related to the gingival tissues only. And proper contour of restoration is essential for the health of the periodontal tissues. But there are so many controversies about the contour of the restoration, and there is no uniform agreement in the literature as to which contour of restoration is best for periodontium. In general, the contour of restoration means the supragingival contour only but in the case of the intracrevicular restorative procedure the subgingival contour of restoration must be considered. Because a portion of the restoration is placed in a gingival sulcus which is extremely vulnerable to periodontal disease. In this article the concepts or theories of the supragingival contour, the subgingival contour, and the emergence profile were discussed. The contour of the restoration and the biotype of the periodontium must be considered in intracrevicular restorative procedure. And sufficient tooth preparation is important factor to develop the proper contour of restoration which is kind to periodontium.
Periodontal Diseases ; Periodontium ; Tooth Preparation

No abstract available.
Adult* ; Chronic Periodontitis* ; Doxycycline* ; Humans

No abstract available.
Gingival Crevicular Fluid* ; Periodontal Diseases*

Chitosan has been known as a wound healing agent. The purpose of this study was to evaluate the biocompatibility and guided bone regenerative effect of chitosan and chitosan-cellulose membranes. The effects of chitosan and chitosan-cellulose membranes on the growth and survival of human periodontal ligament cells were examined by rapid colorimetric MTT(tetrazolium) assay, and the tissue response and resorption pattern were observed by implanting the membranes into the subcutaneous tissue of the back of rats for 6 weeks. To evaluate the guided bone regenerative potential of membranes, the amount of newly formed bone in the rat calvarial defects(8mm in diameter) was measured by histomorphometry and radiomorphometry 1,2 and 4 weeks after implantation of membranes. Chitosan and chitosan-cellulose membranes showed no adverse effect on the growth and survival of human periodontal ligament cells. When membranes were subcutaneously implanted, inflammatory reaction was observed at 1 week and which gradually subsided 2 weeks after implantation. Membranes remained intact throughout the experimental period of 6 weeks. Radiomorphometric analysis of the craniotomy sites revealed that chitosan and chitosan-cellulose membrane implanted sites showed increased radiopacity over control. Statistically significant differences with control were found in chitosan-cellulose membrane implanted group at 2 and 4 weeks, and chitosan membrane implanted group at 4 weeks(P<0.05). Histomorphometric data indicated a pattern of osseous healing similar to radiomorphometric analysis. There was a statistically significant difference between control and chitosan-cellulose membrane implanted group at 4 weeks(P<0.05). These results implicate that chitosan and chitosan-cellulose membrane might be useful for guided bone regeneration.
Humans ; Rats ; Animals

The objective of the present study was to investigate the vertical and horizontal location of the molar furcations in korean. The samples used in this study included 132 maxillary molars and 120 mandibular molars. Of them, 47 maxillary molars and 34 mandibular molars had the fused roots. So, 85 maxillary molars(54 1st and 31 2nd molars) and 86 mandibular molars(46 1st and 40 2nd molars) were measured. The vertical and horizontal location of molars were measured with divider and digimatic micrometer and their means and standard deviation calculated. The results were summarized as follows: 1. The ratio of fused roots found in this study was the highest in the maxillary second molars with 59%, followed by mandibular second molars(46%) and maxillary first molars(7%) and none were discovered in the mandibular first molars. 2. In the study of the vertical location of molar furcation, the results were as follows : In the maxillary first molars, the length in descending order were distal(5.06mm), mesial(4.52mm) and buccal(4.01mm) and in the maxillary second molar, distal(4.04mm), mesial(4.02mm) and buccal(3.87mm). In the mandibular first molar, the length was 3.69mm on the lingual side and 2.81mm on the buccal side, and in the mandibular second molar, 3.87mm on the lingual and 3.61mm on the buccal side. 3. The location of the mesial and distal furcations in horizontal dimension measured showed following results : buccal and mesial furcations of the maxillary molars and buccal and lingual furcations of the mandibular molars generally found at the center, but the mesial furcation of the maxillary molars were found approximately two thirds toward the palatal aspect.

Lovastatin is a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, which catalyzes the conversion of hydroxymethylglutaryl-coenzyme A to mevalonate, anearly and rate-limiting step in the synthesis of cholesterol. We studied the therapeutic effect and safety of lovastatin in 18 patients with nonfamilial primary hypercholesterolemia. Patients received 20mg/day lovastatin therapy as a single evening dose. If the total cholesterol level exceeded 200mg/dl after 2weeks of lovastatin therapy, the dosage of lovastatin was doubled. Mean percent total cholesterol level reductions from baseline were 26.4% and 31.9% after 4, and 8 weeks of lovastatin therapy respectively. Mean percent HDL-cholesterol level increase from baseline were 12% and 13% after 4, and 8 weeks of lovastatin therapy respectively. Adverse effects attributable to lovastatin were mild and temporary and no patient was withdrawn from therapy. We concluded that lovastatin was a well tolerated and effective agent for the treatment of nonfamilial primary hypercholesterolemia. Further studies are needed to establish the long-term safety and effectiveness of this drug.
Cholesterol ; Coenzyme A ; Humans ; Hypercholesterolemia* ; Lovastatin ; Mevalonic Acid ; Oxidoreductases

BACKGROUND: A clinical trial was performed to evaluate the antihypertensive efficacy and side effects of amlodipine, a new long-action calcium antagonist, in patients with mild to moderate essential hypertension as measured by 24-h ambulatory blood pressure monitoring. METHODS AND RESULTS: 1) The study patients consisted of 4 men and 6 women, and the mean age was 51 years. Amlodipine monotherapy(5~10mg) was continued for 4 weeks, and blood pressure was measured by 24-h ambulatory blood pressure monitoring. 2) A smooth and sustained lowering of blood pressure was clearly achieved without affecting the circadian rhythm throughout dosing interval. The mean-pressure drop was 21.2/13.7mmHg after 4 weeks of amlodipine monotherapy. 3) The ambulatory pulse rate revealed virtually identical average hourly pulses during the recording period before and after amlodipine treatment. 4) All of the laboratory parameters including blood chemistry, glucose, lipid and electrolytes did not change significantly after 4 weeks of amlodipine monotherapy. 5) Amlodipine therapy resulted in minimal side effects that were well tolerated. CONCLUSIONS: Once-daily amlodipine monotherapy with 5 to 10mg in controlling blood pressure throughout each 24-h cycle is effective and well tolerated in the patients with mild to moderate essential hypertension.
Amlodipine* ; Blood Pressure Monitoring, Ambulatory ; Blood Pressure* ; Calcium ; Chemistry ; Circadian Rhythm ; Electrolytes ; Female ; Glucose ; Heart Rate ; Humans ; Hypertension ; Male